Foster Group’s GSK GSK Stock Holding History

Foster Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-3,875	Closed	-$203K	–	326
2026 Q2	$203K	Buy	+3,875	New	+$205K	0.01%	304

Other funds holding GSK

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

KFP

Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return

KIC

Keating Investment Counselors Delray Beach, Florida $382M AUM 16.71% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Gilman Hill Asset Management New Canaan, Connecticut $718M AUM 15.3% 1-Year Est. Return

ARS Wealth Advisors Group St. Petersburg, Florida $1.37B AUM 18.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

RWA

Roberts Wealth Advisors Palo Alto, California $445M AUM 20.18% 1-Year Est. Return

Foster Group's GSK Position: Q3 2026 in Review

Foster Group sold out of GSK (GSK) in Q3 2026, closing a stake of 3,875 shares — an estimated $203K sold.

Foster Group first reported a position in GSK in Q2 2026 and held it in 1 quarter. The position peaked at $203K in Q2 2026. 159 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Foster Group reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
Foster Group sold 3,875 GSK shares in Q3 2026, an estimated $203K.
Foster Group first reported a position in GSK in Q2 2026 and held it in 1 quarter.
Foster Group's GSK position peaked at $203K in Q2 2026.
159 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.